References
Wermers RA, Recknor CP, Cosman F, Xie L, Glass EV, Krege JH (2008) Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate. Osteoporos Int 19:1055–1065 doi:10.1007/s00198-007-0557-z
Greenspan SL, Bone HG, Ettinger MP et al (2007) Effect of recombinant human parathyroid hormone (1–84) on vertebral fractures and bone mineral density in postmenopausal women with osteoporosis. Ann Intern Med 146:326–339
Brown EM, Jüppner H (2006) Parathyroid hormone: synthesis, secretion, and action. In: Favus MJ (ed) Primer on the metabolic bone disease and disorders of mineral metabolism. 6th edn. Cadmus Professional Communications, Richmond, VA, USA, pp 90–99
Author information
Authors and Affiliations
Corresponding author
Additional information
A reply to this letter can be found at http://dx.doi.org/10.1007/s00198-008-0733-9.
Rights and permissions
About this article
Cite this article
Minisola, S., Piemonte, S., Del Fiacco, R. et al. Measuring serum calcium before and after teriparatide treatment. Osteoporos Int 19, 1807 (2008). https://doi.org/10.1007/s00198-008-0732-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-008-0732-x